FDA Post-Market Safety Efforts Won’t Be Impacted By Sentinel In Near Term

FDA's Sentinel post-market safety monitoring project will augment, not replace, the agency's current repertoire of post-market activities and requirements for drugs, Center for Drug Evaluation and Research Director Janet Woodcock emphasized